Vanguard Group Inc. cut its holdings in Genpact Limited (NYSE:G - Free Report) by 2.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 16,103,229 shares of the business services provider's stock after selling 403,990 shares during the period. Vanguard Group Inc. owned 9.34% of Genpact worth $753,309,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of the business. Concurrent Investment Advisors LLC raised its holdings in Genpact by 84.6% in the 4th quarter. Concurrent Investment Advisors LLC now owns 9,461 shares of the business services provider's stock valued at $443,000 after acquiring an additional 4,336 shares during the last quarter. Chicago Partners Investment Group LLC raised its holdings in Genpact by 79.3% in the 4th quarter. Chicago Partners Investment Group LLC now owns 26,870 shares of the business services provider's stock valued at $1,231,000 after acquiring an additional 11,880 shares during the last quarter. Davis Capital Management increased its holdings in shares of Genpact by 1.6% during the 4th quarter. Davis Capital Management now owns 40,434 shares of the business services provider's stock worth $1,892,000 after buying an additional 649 shares during the last quarter. West Michigan Advisors LLC acquired a new stake in shares of Genpact during the 4th quarter worth $214,000. Finally, HB Wealth Management LLC increased its holdings in shares of Genpact by 20.4% during the 4th quarter. HB Wealth Management LLC now owns 11,768 shares of the business services provider's stock worth $551,000 after buying an additional 1,997 shares during the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Genpact Stock Down 1.1%
Shares of Genpact stock opened at $34.36 on Friday. The company has a fifty day moving average price of $37.51 and a 200 day moving average price of $41.45. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.46. Genpact Limited has a twelve month low of $33.14 and a twelve month high of $50.41. The stock has a market cap of $5.83 billion, a price-to-earnings ratio of 10.98, a price-to-earnings-growth ratio of 1.01 and a beta of 0.61.
Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings results on Friday, February 6th. The business services provider reported $0.97 earnings per share for the quarter, topping analysts' consensus estimates of $0.93 by $0.04. Genpact had a net margin of 10.88% and a return on equity of 22.02%. The firm had revenue of $1.32 billion during the quarter, compared to analysts' expectations of $1.31 billion. During the same period in the prior year, the company earned $0.91 EPS. The firm's revenue was up 5.6% on a year-over-year basis. Equities research analysts forecast that Genpact Limited will post 3.6 earnings per share for the current fiscal year.
Genpact Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Wednesday, June 10th will be given a dividend of $0.1875 per share. The ex-dividend date of this dividend is Wednesday, June 10th. This represents a $0.75 annualized dividend and a yield of 2.2%. Genpact's payout ratio is 23.96%.
Wall Street Analysts Forecast Growth
G has been the subject of a number of research analyst reports. Wall Street Zen downgraded Genpact from a "buy" rating to a "hold" rating in a report on Saturday, March 14th. Needham & Company LLC dropped their price objective on Genpact from $53.00 to $50.00 and set a "buy" rating for the company in a report on Friday, February 6th. Mizuho dropped their price objective on Genpact from $51.00 to $49.00 and set a "neutral" rating for the company in a report on Tuesday, February 10th. Susquehanna set a $42.00 price objective on Genpact in a report on Friday, February 6th. Finally, Citigroup upgraded Genpact from a "hold" rating to a "strong-buy" rating in a report on Friday, February 13th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $47.29.
Read Our Latest Stock Report on Genpact
Insiders Place Their Bets
In other Genpact news, CEO Balkrishan Kalra sold 2,800 shares of the company's stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $40.77, for a total value of $114,156.00. Following the completion of the transaction, the chief executive officer directly owned 525,007 shares of the company's stock, valued at $21,404,535.39. This represents a 0.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.58% of the stock is currently owned by insiders.
Genpact Profile
(
Free Report)
Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.
Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.
Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report